Are antipsychotic drugs interchangeable?

Journal of Nervous and Mental Disease

Volumn 159, Issue 5, 1974, Pages 343-348

  Gardos, George ^a  

^a Psychological Consultant for the Freeport Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE;

DRUG COMPARISON; DRUG INDUSTRY; DRUG THERAPY; SCHIZOPHRENIA; THERAPY;

ATTITUDE; CHLORPROMAZINE; CHRONIC DISEASE; CLINICAL TRIALS; COMPARATIVE STUDY; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FLUPHENAZINE; FOSTER HOME CARE; HUMAN; PATIENT DROPOUTS; RECURRENCE; SCHIZOPHRENIA; THERAPEUTIC EQUIVALENCY; THIORIDAZINE; THIOTHIXENE; TIME FACTORS; TRIFLUOPERAZINE;

EID: 0016260265     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/00005053-197411000-00004     Document Type: Article

References (14)

1. Caffey, E. M., Jr., Hollister, L. E., Kaim, S. C, and Pokorny, A. D. A survey of drug treatment in psychiatry. In DiMascio A., and Shader, R. I., Eds. Clinical Handbook of Psychopharmacology, pp. 343-384. Science House, New York, 1970.
2. DiMascio, A., and Shader, R. I. Behavioral toxicity. In Efron, D. H., Ed. Psycho-pharmacology: A Review of Progress, pp. 551-560. U.S. Govt. Printing Office PHS Publ. 1836, Washington, D.C., 1968.
3. Galbrecht, C. R., and Klett, C. J. Predicting response to phenothiazines: The right drug for the right patient. J. Nerv. Ment. Dis., 147: 173-183, 1968.
4. Goldberg, S. C. Prediction of drug response to antipsychotic drugs. In Efron, D. H., Ed. Psychopharmacology: A Review of Progress, pp. 1101-1117. U.S. Govt. Printing Office, PHS Publ. 1836, Washington, D.C., 1968.
5. Greenberg, L., and Roth, S. Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients. Am. J. Psychiatry, 123: 221-226, 1966.
6. Hogarty, G. E., and Goldberg, S. C. Drug and sociotherapy in the aftercare of schizophrenic patients. Arch. Gen. Psychiatry, 28: 54-64, 1973.
7. Hollister, L. E., Overall, J. E., Bennett, J. L., Kimball, I., and Shelton, J. Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients. Clin. Pharmacol. Ther., 8: 249-255, 1967.
8. Klett, C. J., and Moseley, E. C. The right drug for the right patient. J. Consult. Psychol., 29: 546-551, 1965.
9. Prien, R. F., and Klett, C. J. An appraisal of the long-term use of tranquilizing medication with hospitalized chronic schizophrenics: A review of the drug discontinuation literature. Schizo. Bull., 5: 64-73, 1972.
10. Prien, R. F., Cole, J. O., and Belkin, V. Abrupt withdrawal of tranquilizing medication. Br. J. Psychiatry, 115: 679-686, 1969.
11. Prien, R. F., Levine, J., and Switalski, R. W. Discontinuation of chemotherapy in chronic schizophrenia: Results from two collaborative studies. Hosp. Commun. Psychiatry, 22: 20-23, 1971.
12. Rassidakis, N. C, Kondakis, X., Papanastassiou, A., and Michalakeas, A. Withdrawal of antipsychotic drugs from chronic patients. Bull. Menninger Clin., 34: 216-222, 1970.
13. Whittaker, C. B., and Hoy, R. M. Withdrawal of perphenazine in chronic schizophrenia. Br. J. Psychiatry, 109: 422-427, 1963.
14. Wiener, D. N., Feinberg, P., Nagobads, I. J., Westendorf, F., and Warren, P. W. Effects of withdrawal of tranquilizers. Arch. Gen. Psychiatry, 9: 513-519, 1963.